Histogen Company Leadership
| HSTO Stock | USD 0.02 0.01 25.65% |
Histogen employs about 7 people. The company is managed by 5 executives with a total tenure of roughly 17 years, averaging almost 3.0 years of service per executive, having 1.4 employees per reported executive. Analysis of Histogen's management performance can provide insight into the firm performance.
Histogen |
Histogen Management Team Effectiveness
The company has return on total asset (ROA) of (0.5381) % which means that it has lost $0.5381 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (1.1989) %, meaning that it created substantial loss on money invested by shareholders. Histogen's management efficiency ratios could be used to measure how well Histogen manages its routine affairs as well as how well it operates its assets and liabilities. As of the 23rd of November 2024, Return On Tangible Assets is likely to drop to -0.67. In addition to that, Return On Capital Employed is likely to drop to -0.72. At this time, Histogen's Total Assets are very stable compared to the past year. As of the 23rd of November 2024, Non Current Assets Total is likely to grow to about 6.8 M, while Total Current Assets are likely to drop about 11.5 M.As of the 23rd of November 2024, Common Stock Shares Outstanding is likely to grow to about 4.5 M, while Net Loss is likely to drop (13.4 M).
Histogen Workforce Comparison
Histogen is rated below average in number of employees category among its peers. The total workforce of Health Care industry is currently estimated at about 1,261. Histogen maintains roughly 7.0 in number of employees contributing less than 1% to equities under Health Care industry.
Histogen Insider Trading
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Histogen insiders, such as employees or executives, is commonly permitted as long as it does not rely on Histogen's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases, Histogen insiders must file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Spada Alfred P over a year ago Acquisition by Spada Alfred P of 313436 shares of Histogen subject to Rule 16b-3 | ||
Satz Brian over a year ago Acquisition by Satz Brian of 6835 shares of Histogen subject to Rule 16b-3 | ||
Spada Alfred P over a year ago Acquisition by Spada Alfred P of 106793 shares of Histogen subject to Rule 16b-3 | ||
Spada Alfred P over a year ago Histogen exotic insider transaction detected |
Histogen Notable Stakeholders
A Histogen stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Histogen often face trade-offs trying to please all of them. Histogen's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Histogen's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
| Susan Knudson | CEO, President | Profile | |
| Stephen Hill | VP Controller | Profile | |
| Steven Mento | Interim Chairman | Profile | |
| Thomas Hubka | Director Sec | Profile | |
| Gail Naughton | Founder Advisor | Profile |
About Histogen Management Performance
The success or failure of an entity such as Histogen often depends on how effective the management is. Histogen management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Histogen management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Histogen management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | (0.64) | (0.67) | |
| Return On Capital Employed | (0.69) | (0.72) | |
| Return On Assets | (0.64) | (0.67) | |
| Return On Equity | (0.85) | (0.89) |
Histogen Workforce Analysis
Traditionally, organizations such as Histogen use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Histogen within its industry.Histogen Manpower Efficiency
Return on Histogen Manpower
| Revenue Per Employee | 2.7K | |
| Revenue Per Executive | 3.8K | |
| Net Loss Per Employee | 1.8M | |
| Net Loss Per Executive | 2.5M | |
| Working Capital Per Employee | 1.7M | |
| Working Capital Per Executive | 2.4M |
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Histogen. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate. To learn how to invest in Histogen Stock, please use our How to Invest in Histogen guide.You can also try the ETF Categories module to list of ETF categories grouped based on various criteria, such as the investment strategy or type of investments.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Histogen. If investors know Histogen will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Histogen listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (2.81) | Revenue Per Share 0.004 | Return On Assets (0.54) | Return On Equity (1.20) |
The market value of Histogen is measured differently than its book value, which is the value of Histogen that is recorded on the company's balance sheet. Investors also form their own opinion of Histogen's value that differs from its market value or its book value, called intrinsic value, which is Histogen's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Histogen's market value can be influenced by many factors that don't directly affect Histogen's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Histogen's value and its price as these two are different measures arrived at by different means. Investors typically determine if Histogen is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Histogen's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.